And here with the registration link: ESC 365 - Are beta-blockers still indicated after myocardial infarction?   https://t.co/bvF9o8egzf

Any HCP who is involved in post-MI care: this ESC Webinar may be of interest to you: #Oslo Center for Clinical Heart Research # Escardio webinars

Any HCP who is involved in post-MI care: this ESC Webinar may be of interest to you: #Oslo Center for Clinical Heart Research # Escardio webinars

My @TCTMD LBT interview with @dan_atar and @Borjaibanez1 around REBOOT-CNIC and BETAMI-DANBLOCK trials @escardio ➡️ https://t.co/gGTdWPyejv @Hragy @mirvatalasnag @hvanspall @DrMarthaGulati @purviparwani @SVRaoMD @SandeepNathanMD @iamritu

Honored and humble to present the BETAMI-DANBLOCK trial on behalf of a combined Norwegian and Danish cardiovascular community. The main auditorium in Madrid was packed. https://t.co/D5ZtOVY8S2 #Oslo Center for Clinical Heart Research

#ESCCongress is almost here! Don't miss 🔥 Hot Line discussions with 💫 Dr @hvanspall & expert guests: Prof @FaiezZANNAD, Prof @dan_atar, Dr Anna Meta Dyrvig Kristensen, Prof Michael Borger, Prof Udo Bavendiek, Prof @j_rvl & Dr Julie De Backer. 🫀 Cutting-edge insights,

Exciting new clinical science coming your way at ESC. Join us on Saturday 30/8 at 11:00-12:00 CET. #Oslo Center for Clinical Heart Research

#ESCcongress2025 Hotine#3. Two large trials (@RebootTrial (n=8500) & betami+danblock (n=5500 together)) PLUS a metaanalysis of them focused in the subgroup of Pt with mildly reduced LVEF are presented. Stay tuned!!

TEN HOT LINES ❤️‍🔥10 hot line sessions already released by @escardio #ESCcongress ❤️‍🔥They feature 42 major trials alongside 129 exciting additional studies ❤️‍🔥Spanish trials lead one of them, highlighitng ⬆️level of scientific research https://t.co/9mwtjhp90n @RosselloJavier #CardioX

Check out our webinar on various aspects of cardio-oncology recorded yesterday in Stockholm: https://t.co/sepgZLxiB4 @dan_atar @CTCPR_ @RigsHeart

En minneverdig dag den 25/4/2025 med uhyre spennende vitenskapelige diskusjoner i anledning dr. Camilla Settergren sin disputas på Karolinska instituttet. Takk for å få den ærefulle oppgaven som opponent. Gratulerer til kandidaten og hennes 4 enestående veiledere 👏🎼🥂

New ESC WG on Thrombosis consensus statement! Antithrombotic therapy in patients with congenital bleeding disorders—balancing thrombotic risk with bleeding management. 📖   https://t.co/SHVebuMTdC @dan_atar @EditorEHJCVP #ESCThorombosis

Hard to find a more star-spangled faculty…😊   The European Heart Academy under the ESC is a proud co-sponsor of this postgraduate course.   We look forward to welcoming today’s participants into our EHA-Alumni community once they have graduated.              #ESC

Enormously honored and proud to present at the famous “Oxford Master Course in Clinical Trials” alongside some of the World’s most famous trialists: Sir Richard Peto, Sir Rory Collins, Professors Colin Baigent, Jane Armitage, Louise Bowman, Amanda Adler, Peter Jüni.

@RosselloXavier @escardio @ESC_Journals @Borjaibanez1 @j_alvarezgarcia @cpgale3 @JavedButler1 @john_munkhaugen @dan_atar @GreggWStone @rafavidalperez @SonEspases @idisbaib Hopefully our findings, which would be soon revealed alongside the results of the BETAMI-DANBLOCK trial, will contribute to a level of evidence A of future ACS guidelines! @Borjaibanez1 @S_Raposeiras @JovenesSec @CVCTForum @FaiezZANNAD @GreggWStone @JavedButler1 @hvanspall

Congratulations Gabriel! My sincere honor and reverence to your family!

https://t.co/frWxkVksQK

Since December 2024, The International Scientific Board of our journal has 17 members! We are honored to announce that new members are: @dan_atar , @BorianiGiuseppe , Filippo Crea, @LindeCecilia and Gregory Lip. We hope that their support will enhance the journal's standing!

Thanks again for the invitation to present at the Norwegian Society of Cardiology! Great to see many friends including @BeitnesJan @pmyhre @ThorEdvardsen @dan_atar! Looking forward to collaborate on pragmatic RCTs very soon! And look at the beautiful venue for the meeting 👇

Elevated #NatriureticPeptides and #troponins are strong predictors of #HF events, but ever wondered if these biomarkers predict worsening cardiac structure & function? We analyzed NT-proBNP, TnT and TnI in a/w serial echo in ~2000 👤 in #ARIC Just published in @CircAHA 🧵 /5